Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
NCT00622843
Completed
Purpose: To study the immune response of the newly licensed pneumococcal conjugate vaccine (PCV) in comparison to the pneumococcal polysaccharide vaccine (PPV) to determine if a significantly better immunologic response to boosting can be elicited in patients previously vaccinated with PPV.
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
10/07/2014
Locations: Tripler Army Medical Center, Tripler AMC, Hawaii
Conditions: HIV Infections, Streptococcus Pneumoniae
Register for Updates
Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
NCT00006470
Completed
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining these two treatments may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining vaccine therapy with radiation therapy in treating patients who have stage II or stage IIIA non-small cell lung cancer that has been completely removed in surgery.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/09/2013
Locations: MBCCOP - Hawaii, Honolulu, Hawaii
Conditions: Lung Cancer
Register for Updates
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
NCT00806195
Completed
The primary objective of this phase 3b study is to evaluate the safety and tolerability of Novartis MenACWY conjugate vaccine when administered with routine infant vaccinations to healthy infants
Gender:
ALL
Ages:
Between 55 days and 89 days
Trial Updated:
05/13/2013
Locations: 132 Kaiser Permanente Pediatric - Mapunapuna 2828 Paa Street, 2nd Floor, Honolulu, Hawaii +1 locations
Conditions: Meningitis, Meningococcal Infection
Register for Updates
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT00003386
Terminated
RATIONALE: Vaccines made from tumor tissue may make the body build an immune response and kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have stage III or stage IV ovarian epithelial cancer.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
04/10/2013
Locations: MBCCOP - Hawaii, Honolulu, Hawaii
Conditions: Ovarian Cancer
Register for Updates
S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
NCT00045617
Terminated
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. Vaccines may make the body build an immune response to kill tumor cells. Combining chemotherapy and radiation therapy with vaccine therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining chemotherapy and radiation therapy with vaccine therapy in treating patients who hav... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/11/2012
Locations: Cancer Research Center of Hawaii, Honolulu, Hawaii +1 locations
Conditions: Lung Cancer
Register for Updates
Safety Study of HBV-002 West Nile Vaccine in Healthy Adults
NCT00707642
Completed
The purpose of this Phase 1 trial is to evaluate the clinical safety of HBV-002 vaccine in healthy adults.
Gender:
ALL
Ages:
Between 18 years and 45 years
Trial Updated:
06/13/2009
Locations: Covance Clinical Research Unit, Honolulu, Hawaii
Conditions: West Nile Virus Disease
Register for Updates